Article Information
History
- October 7, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Brittany A. Comunale†,1,
- Erin Jackson-Ward1,2,
- Yong Jiang3,
- Laura P. Ward4,
- Qianna Liu3,
- Lyuqing Ji3,
- Michelle Lai3,
- Lilly Engineer1,5,
- Roderick A. Comunale6 and
- Qiyi Xie7
- 1Department of Health Policy and Management, Johns Hopkins University, Baltimore, MD, USA
- 2Cedars-Sinai, Los Angeles, CA, USA
- 3America Diagnostics, Inc., San Diego, CA, USA
- 4McLean Hospital, Belmont, MA, USA
- 5Department of Anesthesiology and Critical Care Medicine, Johns Hopkins School of Medicine, Baltimore, MD, USA
- 6Clinical Research Division, RAC, Inc., San Diego, CA, USA
- 7E-Mo Biology, Inc., Arcadia, CA, USA
- ↵†Corresponding author. Email: BComunale{at}jhu.edu
Posted October 07, 2021.
Inactivated Poliovirus Vaccine Induces Antibodies that Inhibit RNA Synthesis of SARS-CoV-2: An open-label, pre-post vaccine clinical trial
